SEC 13F Intelligence

Forsta Ap-Fonden / VRTX

Forsta Ap-Fonden’s Vertex Pharmaceuticals Inc Position

Does Forsta Ap-Fonden own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 53.5K shares worth $24M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q4 2025
Shares
53.5K
% of Portfolio
+0.14%
Quarters Held
24
position exited

Position History VRTX

Reported value by quarter
Q1 ’20: $7MQ1 ’20Q2 ’20: $10MQ3 ’20: $16MQ4 ’20: $17MQ4 ’20Q1 ’21: $13MQ2 ’21: $16MQ3 ’21: $14MQ3 ’21Q4 ’21: $17MQ1 ’22: $15MQ2 ’22: $15MQ2 ’22Q3 ’22: $16MQ4 ’22: $18MQ1 ’23: $22MQ1 ’23Q2 ’23: $25MQ3 ’23: $25MQ4 ’23: $30MQ4 ’23Q1 ’24: $23MQ2 ’24: $25MQ3 ’24: $28MQ3 ’24Q4 ’24: $24MQ1 ’25: $28MQ2 ’25: $23MQ2 ’25Q3 ’25: $22MQ4 ’25: $24Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202553.5K$24M+0.14%
Q3 202555.0K$22M+0.13%
Q2 202552.0K$23M+0.15%
Q1 202558.2K$28M+0.21%
Q4 202458.7K$24M+0.17%
Q3 202459.9K$28M+0.21%
Q2 202453.9K$25M+0.22%
Q1 202455.7K$23M+0.20%
Q4 202373.7K$30M+0.30%
Q3 202373.1K$25M+0.28%
Q2 202372.1K$25M+0.27%
Q1 202369.7K$22M+0.26%
Q4 202261.4K$18M+0.20%
Q3 202254.8K$16M+0.19%
Q2 202253.9K$15M+0.20%
Q1 202257.5K$15M+0.17%
Q4 202177.3K$17M+0.17%
Q3 202176.2K$14M+0.16%
Q2 202178.3K$16M+0.19%
Q1 202160.0K$13M+0.18%
Q4 202071.3K$17M+0.25%
Q3 202058.4K$16M+0.33%
Q2 202035.3K$10M+0.27%
Q1 202031.3K$7M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forsta Ap-Fonden’s full portfolio or all institutional holders of VRTX.